Kalehua Capital Management
Latest statistics and disclosures from Kalehua Capital Management's latest quarterly 13F-HR filing:
- Central Index Key (CIK): 0002106181
Tip: Access up to 7 years of quarterly data
Positions held by Kalehua Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Kalehua Capital Management
Kalehua Capital Management holds 25 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Alpha Architect 1-3 Month Box ETF Alpha Arch 1-3 (BOXX) | 18.0 | $25M | 218k | 116.29 |
|
|
| X4 Pharmaceuticals Com New (XFOR) | 10.9 | $15M | 3.7M | 4.13 |
|
|
| Surrozen Com New (SRZN) | 7.9 | $11M | 385k | 29.13 |
|
|
| Veradermics Common Stock | 6.5 | $9.2M | 146k | 63.15 |
|
|
| Relay Therapeutics (RLAY) | 6.3 | $9.0M | 902k | 9.95 |
|
|
| Sionna Therapeutics (SION) | 5.6 | $7.9M | 197k | 40.09 |
|
|
| Aclaris Therapeutics (ACRS) | 4.9 | $6.9M | 1.8M | 3.75 |
|
|
| Inhibikase Therapeutics Com New (IKT) | 4.5 | $6.4M | 3.8M | 1.68 |
|
|
| Oruka Therapeutics (ORKA) | 4.1 | $5.8M | 119k | 49.05 |
|
|
| Pharvaris N V (PHVS) | 4.0 | $5.6M | 199k | 28.25 |
|
|
| Uniqure NV SHS (QURE) | 3.4 | $4.8M | 291k | 16.35 |
|
|
| Septerna (SEPN) | 3.3 | $4.7M | 195k | 24.03 |
|
|
| Compass Pathways Sponsored Ads (CMPS) | 3.2 | $4.5M | 820k | 5.53 |
|
|
| Athira Pharma (LONA) | 2.9 | $4.0M | 394k | 10.28 |
|
|
| Damora Therapeutics Com New (DMRA) | 2.5 | $3.6M | 139k | 25.90 |
|
|
| Gossamer Bio (GOSS) | 2.4 | $3.4M | 10M | 0.33 |
|
|
| MoonLake Immunotherapeutics Class A Ord (MLTX) | 2.3 | $3.3M | 176k | 18.64 |
|
|
| Tyra Biosciences (TYRA) | 2.0 | $2.9M | 75k | 38.30 |
|
|
| Pepgen (PEPG) | 1.3 | $1.8M | 1.0M | 1.77 |
|
|
| Instil Bio Com New (TIL) | 1.1 | $1.5M | 183k | 8.24 |
|
|
| Tenaya Therapeutics (TNYA) | 1.0 | $1.4M | 2.0M | 0.69 |
|
|
| Korro Bio (KRRO) | 0.9 | $1.2M | 109k | 11.32 |
|
|
| Kalaris Therapeutics (KLRS) | 0.6 | $782k | 136k | 5.77 |
|
|
| DiaMedica Therapeutics Com New (DMAC) | 0.3 | $423k | 63k | 6.77 |
|
|
| Loop Inds (LOOP) | 0.3 | $361k | 348k | 1.04 |
|
Past Filings by Kalehua Capital Management
SEC 13F filings are viewable for Kalehua Capital Management going back to 2026
- Kalehua Capital Management 2026 Q1 amended filed May 15, 2026